Acute respiratory distress syndrome (ARDS) is a severe lung condition characterized by fluid buildup in the air sacs, causing breathing difficulties. Its primary application lies in critical care medicine, particularly in intensive care units (ICUs). ARDS features include rapid onset of breathing distress, low oxygen levels, and chest X-rays showing opacities. Its uses encompass diagnosing and managing severe respiratory failure, requiring mechanical ventilation, and addressing underlying causes such as infections or trauma. Timely intervention is crucial, often involving ventilatory support and treatments to mitigate lung inflammation and improve oxygenation.
According to Data Bridge Market Research, the Global Acute Respiratory Distress Syndrome (ARDS) Market is accounted to reach USD 1,29,655.84 million in 2022 and is expected to reach USD 2,79,956.55 million by 2030. The market is expected to grow with a CAGR of 10.1% in the forecast period of 2023 to 2030.
“Increase in product launches boosts the market’s growth”
The acute respiratory distress syndrome (ARDS) market is experiencing growth driven by an increase in product launches. As the healthcare industry witnesses innovations in medical devices, treatments, and pharmaceuticals for ARDS management, there's heightened market activity. New product introductions cater to unmet medical needs, offering improved patient outcomes and enhanced therapeutic options. These launches boost market expansion by providing healthcare professionals with more effective tools and treatments for addressing ARDS, ultimately contributing to the growth of the ARDS market.
What restraints the growth of the global acute respiratory distress syndrome (ARDS) market?
“Shortage of skilled professionals restraints the market’s growth”
The growth of the acute respiratory distress syndrome (ARDS) market faces a significant restraint in the form of a shortage of skilled professionals. ARDS management often requires specialized medical expertise and advanced technologies. The limited number of healthcare professionals with the necessary skills and experience can hinder the efficient diagnosis and treatment of ARDS cases. This shortage may result in delayed interventions and suboptimal patient care, impacting the market's growth potential as the demand for qualified personnel outpaces supply in this critical healthcare segment.
Segmentation: Global Acute Respiratory Distress Syndrome (ARDS) Market
The global acute respiratory distress syndrome (ARDS) market is segmented on the basis of cause, type, route of administration, end user, and distribution channel.
- On the basis of cause, the acute respiratory distress syndrome (ARDS) market is segmented into coronavirus disease 2019 (COVID-19), sepsis, inhalation of harmful substances, severe pneumonia, and others.
- On the basis of type, the acute respiratory distress syndrome (ARDS) market is divided into diagnosis and treatment.
- On the basis of route of administration, the acute respiratory distress syndrome (ARDS) market is divided into oral, parenteral, and others.
- On the basis of end user, the acute respiratory distress syndrome (ARDS) market is divided into hospitals, specialty clinics, home healthcare, and others.
- On the basis of distribution channel, the acute respiratory distress syndrome (ARDS) market is divided into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others.
Regional Insights: North America dominates the Global Acute Respiratory Distress Syndrome (ARDS) Market
North America dominates the acute respiratory distress syndrome (ARDS) market because of recent technological advancements and the accessibility of innovative pharmacological compounds that have significantly enhanced the therapeutic process. These developments include precision medicine, targeted therapies, and personalized treatment approaches, offering patients more effective and tailored options. As a result, healthcare outcomes are improving, marking a pivotal moment in the evolution of medical treatment.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to an increase in biotechnology research and center activity has stimulated significant advancements in the field. With growing investments and collaborations, researchers are driving innovation, discovering novel therapies, and advancing our understanding of biology, promising breakthroughs in healthcare and beyond.
Recent Developments
- In 2021, Medtronic has recently unveiled the SonarMed airway monitoring system, incorporating acoustic technology to detect obstructions in endotracheal tubes. This innovation marks an expansion in the company's product portfolio, enhancing its offerings in the process.
- In 2020, F. Hoffman-La Roche Ltd. initiated trials for the rapid SARS-CoV-2 antibody test in collaboration with SD Biosensor, Inc. This partnership has led to an expansion of the company's product range.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-acute-respiratory-distress-syndrome-ards-market
The Prominent Key Players Operating in the Global Acute Respiratory Distress Syndrome (ARDS) Market Include:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Bayer AG (Germany)
- Sun Pharmaceutical Industries Ltd (India)
- Novartis AG (Switzerland)
- Drägerwerk AG & Co. KGaA (Germany)
- Fisher & Paykel Healthcare Limited (New Zealand)
- LivaNova PLC (U.K.)
- Besmed Health Business Corp. (Taiwan)
- Armstrong Medical (U.K.)
- Pfizer Inc. (U.S.)
- WEINMANN Emergency Medical Technology GmbH + Co. KG (Germany)
- Terumo Medical Corporation (U.S.)
- Getinge AB. (Sweden)
- EUROSETS (Italy)
Above are the key players covered in the report, to know about more and exhaustive list of global acute respiratory distress syndrome (ARDS) market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Acute Respiratory Distress Syndrome (ARDS) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
